Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the safe and tolerable, biologically active, and potentially effective doses(s) of ALD518 in subjects with acute GVHD, who have failed to respond to glucocort...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
CSL Behring
NCT04373057 · Acute GVHD
NCT02611180 · Acute Graft-versus-host Disease, Acute GVHD, and more
NCT03701698 · Acute GVHD
NCT04645667 · Acute GVHD
NCT02806947 · Acute GVHD
City of Hope
Duarte, California
Loyola Medical Center
Maywood, Illinois
Washington University
St Louis, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions